Cholesterol drug pulled off market

Aug. 8 — Baycol, a cholesterol-lowering drug taken by 700,000 Americans, was pulled off the market Wednesday because of muscle destruction linked to at least 40 deaths around the world. But the Food and Drug Administration urged the millions of Americans who take any of the five other drugs known as statins not to panic.

FDA NEWS
Cholesterol-Lowering Drug Baycol Being Withdrawn.

Bayer Pharmaceutical Division is voluntarily withdrawing Baycol (cerivastatin) from the market following reports of sometimes-fatal rhabdomyolysis, a severe muscle adverse reaction. Baycol was approved in 1997 to treat elevated cholesterol levels. Full story

Wednesday - August 8, 2001
Bayer withdraws cholesterol-lowering drug Baycol/Lipobay
http://www.news.bayer.com/news/news.nsf/ID/01-0219

If you are seeking representation for any of these; please phone us at 817.336.3330, or submit your information here.